CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help (Q77402954)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

title

CD40 antibody evokes a cytotoxic T-cell response that eradicates lymphoma and bypasses T-cell help (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

author name string

French RR

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Chan HT

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Tutt AL

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

Glennie MJ

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

page(s)

548-553

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/8426

5 December 2019

exact match

0 references

cites work

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

1 reference

7 January 2021

CD40 and its ligand, an essential ligand-receptor pair for thymus-dependent B-cell activation

1 reference

7 January 2021

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

1 reference

7 January 2021

CD40 ligand is required for protective cell-mediated immunity to Leishmania major

1 reference

7 January 2021

Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity

1 reference

7 January 2021

Functions of CD40 on B cells, dendritic cells and other cells

1 reference

7 January 2021

A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell.

1 reference

7 January 2021

Help for cytotoxic-T-cell responses is mediated by CD40 signalling.

1 reference

7 January 2021

T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions.

1 reference

7 January 2021

The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb

1 reference

7 January 2021

Enhancement of T cell-independent immune responses in vivo by CD40 antibodies

1 reference

7 January 2021

CD40-activated human B cells: an alternative source of highly efficient antigen presenting cells to generate autologous antigen-specific T cells for adoptive immunotherapy

1 reference

7 January 2021

Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells

1 reference

7 January 2021

Properties of mouse CD40: Cellular distribution of CD40 and B cell activation by monoclonal anti-mouse CD40 antibodies

1 reference

7 January 2021

The SCID but not the RAG-2 gene product is required for S mu-S epsilon heavy chain class switching.

1 reference

7 January 2021

CD4-deficient mice have reduced levels of memory cytotoxic T lymphocytes after immunization and show diminished resistance to subsequent virus challenge.

1 reference

7 January 2021

Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells

1 reference

7 January 2021

CTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.

1 reference

7 January 2021

Major histocompatibility complex class I-restricted cross-presentation is biased towards high dose antigens and those released during cellular destruction

1 reference

7 January 2021

Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs

1 reference

7 January 2021

Production of cytokines by human B cells in health and disease

1 reference

7 January 2021

Cross-priming for a secondary cytotoxic response to minor H antigens with H-2 congenic cells which do not cross-react in the cytotoxic assay

1 reference

7 January 2021

Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens

1 reference

7 January 2021

Induction of a CD8+ cytotoxic T lymphocyte response by cross-priming requires cognate CD4+ T cell help

1 reference

7 January 2021

Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes

1 reference

7 January 2021

Expansion or elimination of B cells in vivo: dual roles for CD40- and Fas (CD95)-ligands modulated by the B cell antigen receptor.

1 reference

7 January 2021

Tumor antigens recognized by T lymphocytes

1 reference

7 January 2021

The induction of skin graft tolerance in major histocompatibility complex-mismatched or primed recipients: primed T cells can be tolerized in the periphery with anti-CD4 and anti-CD8 antibodies

1 reference

7 January 2021

Monoclonal antibodies raised against the idiotype of the murine B cell lymphoma, BCL1 act primarily with heavy chain determinants

1 reference

7 January 2021

Bispecific Ab therapy of B-cell lymphoma: target cell specificity of antibody derivatives appears critical in determining therapeutic outcome

1 reference

7 January 2021

Identifiers

DOI

10.1038/8426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10229232%20AND%20SRC:MED&resulttype=core&format=json

5 December 2019

1 reference